JNJ

188.65

-0.17%↓

ABT

122.92

-1.34%↓

TMO

566.65

+1.1%↑

ISRG

533.11

+0.27%↑

DHR

216.08

+0.06%↑

JNJ

188.65

-0.17%↓

ABT

122.92

-1.34%↓

TMO

566.65

+1.1%↑

ISRG

533.11

+0.27%↑

DHR

216.08

+0.06%↑

JNJ

188.65

-0.17%↓

ABT

122.92

-1.34%↓

TMO

566.65

+1.1%↑

ISRG

533.11

+0.27%↑

DHR

216.08

+0.06%↑

JNJ

188.65

-0.17%↓

ABT

122.92

-1.34%↓

TMO

566.65

+1.1%↑

ISRG

533.11

+0.27%↑

DHR

216.08

+0.06%↑

JNJ

188.65

-0.17%↓

ABT

122.92

-1.34%↓

TMO

566.65

+1.1%↑

ISRG

533.11

+0.27%↑

DHR

216.08

+0.06%↑

Search

Erasca Inc

Aperta

2.42 -1.63

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

2.39

Massimo

2.5

Metriche Chiave

By Trading Economics

Entrata

-2.9M

-34M

Margine di Profitto

-768.16

Dipendenti

103

EBITDA

-2.5M

-38M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+44.07% upside

Dividendi

By Dow Jones

Utili prossimi

10 nov 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

259M

678M

Apertura precedente

4.05

Chiusura precedente

2.42

Punteggio Tecnico

By Trading Central

Fiducia

Bearish Evidence

Erasca Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

30 ott 2025, 23:32 UTC

Azioni calde

Stocks to Watch: Amazon, Reddit, SPS Commerce

30 ott 2025, 23:02 UTC

Utili

AIA Group 3Q Value of New Business Grew

30 ott 2025, 23:45 UTC

Discorsi di Mercato

Gold Edges Higher Amid Prospects of Continued Central-Bank Demand -- Market Talk

30 ott 2025, 23:00 UTC

Utili

Amazon Posts 13% Revenue Jump, Strong Cloud Sales -- 3rd Update

30 ott 2025, 22:59 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Global Equities Roundup: Market Talk

30 ott 2025, 22:59 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Mineral Resources Bear Reckons Lithium Assets May Be Dressed Up For Sale -- Market Talk

30 ott 2025, 22:56 UTC

Discorsi di Mercato

Australia Shares Shaping to Pare Recent Losses -- Market Talk

30 ott 2025, 22:35 UTC

Utili

AIA Group 3Q Value of New Business Margin Was 58.2%, Up 5.7 Ppt on Year >1299.HK

30 ott 2025, 22:35 UTC

Utili

AIA Group 3Q Value of New Business $1.48B Vs. $1.16B>1299.HK

30 ott 2025, 22:31 UTC

Utili

Apple Expects Big December Quarter on iPhone Upgrades -- 2nd Update

30 ott 2025, 22:29 UTC

Utili

Amazon Posts 13% Revenue Jump, Strong Cloud Sales -- 2nd Update

30 ott 2025, 22:27 UTC

Utili

Minas Buenaventura 3Q EPS 66c >BVN

30 ott 2025, 22:27 UTC

Utili

Minas Buenaventura 3Q Rev $431M >BVN

30 ott 2025, 22:27 UTC

Utili

Minas Buenaventura 3Q Net $179M >BVN

30 ott 2025, 22:16 UTC

Discorsi di Mercato
Utili

Amazon's Grocery Delivery Business Gains Ground -- Market Talk

30 ott 2025, 22:14 UTC

Utili

Review & Preview: A Tech Earnings Storm -- Barrons.com

30 ott 2025, 22:00 UTC

Utili
Acquisizioni, Fusioni, Takeovers

The Day Pharma's Weight-Loss Gold Rush Intensified -- WSJ

30 ott 2025, 21:39 UTC

Utili

Amazon Stock Jumps on Earnings Beat. AWS Is Doing Fine. -- Barrons.com

30 ott 2025, 21:26 UTC

Utili

Amazon Stock Jumps on Earnings Beat. AWS Is Doing Fine. -- Barrons.com

30 ott 2025, 21:14 UTC

Discorsi di Mercato
Utili

Apple Sees Record Quarterly Services Revenue -- Market Talk

30 ott 2025, 21:09 UTC

Discorsi di Mercato
Utili

Global Equities Roundup: Market Talk

30 ott 2025, 21:09 UTC

Discorsi di Mercato
Utili

Amazon Says One-Off Costs Ate Into Operating Income -- Market Talk

30 ott 2025, 21:04 UTC

Utili

Apple Expects Big December Quarter on iPhone Upgrades -- Update

30 ott 2025, 21:03 UTC

Utili

Eldorado Gold 3Q Gold Sales Were 116,529 Ounces at Avg Realized Gold Price Per Ounce Sold of $3,527 >ELD.T

30 ott 2025, 21:03 UTC

Utili

Eldorado Gold 3Q Gold Production Was 115,190 Ounces >ELD.T

30 ott 2025, 21:00 UTC

Utili

Eldorado Gold Skouries on Track for 1Q of 2026

30 ott 2025, 21:00 UTC

Utili

Eldorado Gold 3Q Adj EPS 41c >EGO

30 ott 2025, 21:00 UTC

Utili

Eldorado Gold 3Q Rev $434.7M >EGO

30 ott 2025, 21:00 UTC

Utili

Eldorado Gold 3Q Net $56M >EGO

30 ott 2025, 21:00 UTC

Utili

Eldorado Gold 3Q EPS 27c >EGO

Confronto tra pari

Modifica del prezzo

Erasca Inc Previsione

Obiettivo di Prezzo

By TipRanks

44.07% in crescita

Previsioni per 12 mesi

Media 3.4 USD  44.07%

Alto 6 USD

Basso 1 USD

Basato su 5 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Erasca Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

5 ratings

3

Acquista

1

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

1.39 / 1.44Supporto e resistenza

A breve termine

Bearish Evidence

A termine intermedio

Weak Bearish Evidence

A lungo termine

Very Strong Bearish Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Erasca Inc

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. It also develops ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung and colorectal cancer, and advanced gastrointestinal malignancies; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. In addition, it is developing ERAS-801, a central nervous system-penetrant EGFR inhibitor which is in phase 1 clinical trials for the treatment of patients with recurrent glioblastoma multiforme. The company entered into license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
help-icon Live chat